ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,059Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 337

$490K Total Retail Price of All Prescriptions

Rank: 80 out of 337

602 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 602 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 602 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,588 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 579 514 1 3
LISINOPRIL 563 448 2 2
FUROSEMIDE 523 435 3 8
OMEPRAZOLE 397 304 4 4
METFORMIN HCL 387 271 5 12
METOPROLOL TARTRATE 381 325 6 6
LEVOTHYROXINE SODIUM 356 281 7 5
PRAVASTATIN SODIUM 346 295 8 14
ATORVASTATIN CALCIUM 334 304 9 7
SIMVASTATIN 324 250 10 1
ATENOLOL 290 224 11 10
LOSARTAN POTASSIUM 227 213 12 15
SERTRALINE HCL 212 175 13 18
HYDROCHLOROTHIAZIDE 203 143 14 9
HYDROCODONE-ACETAMINOPHEN 166 123 S3 15 13
DONEPEZIL HCL 165 165 16 22
ALLOPURINOL 162 135 17 28
METOPROLOL SUCCINATE 160 122 18 21
ALENDRONATE SODIUM 150 137 19 19
TAMSULOSIN HCL 132 114 20 25
SYNTHROID 128 123 21 41
FENOFIBRATE 119 105 22 48
BENICAR 107 105 23 110
MELOXICAM 107 75 23 54
ZOLPIDEM TARTRATE 103 81 25 23
ADVAIR DISKUS 100 67 26 44
GLIMEPIRIDE 100 57 26 55
CITALOPRAM HBR 100 82 26 17
TERAZOSIN HCL 99 89 29 136
FLUTICASONE PROPIONATE 99 57 29 34
RANITIDINE HCL 95 84 31 30
GABAPENTIN 95 60 31 20
WARFARIN SODIUM 95 93 31 11
PANTOPRAZOLE SODIUM 91 78 34 36
CRESTOR 88 82 35 29
DIGOXIN 85 81 36 58
CLOPIDOGREL 82 75 37 42
DIOVAN 79 59 38 26
TRAMADOL HCL 79 58 38 32
PROAIR HFA 79 43 38 38
GEMFIBROZIL 75 63 41 114
LOVASTATIN 72 53 42 24
TRICOR 69 55 43 134
ISOSORBIDE MONONITRATE ER 68 68 44 70
PREDNISONE 63 48 45 40
GLIPIZIDE ER 63 57 45 69
KLOR-CON M20 62 49 47 65
AZITHROMYCIN 60 49 48 51
CYCLOBENZAPRINE HCL 59 15 R 49 103
NEXIUM 57 44 50 56
CYMBALTA 57 50 50 59
ESCITALOPRAM OXALATE 57 46 50 66
SINGULAIR 56 30 53 113
PLAVIX 56 47 53 74
QUINAPRIL HCL 54 50 55 50
GLYBURIDE 54 30 R 55 53
LIPITOR 53 37 57 33
CIPROFLOXACIN HCL 53 44 57 71
TRAZODONE HCL 52 36 59 16
VENLAFAXINE HCL ER 51 26 60 86
MECLIZINE HCL 50 44 61 117
SPIRONOLACTONE 50 50 61 100
GLIPIZIDE 50 29 61 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.